The GyLDa Platform

GyLDa Gynecological Liquid Diagnostic represents a breakthrough in diagnostic science.

Harnessing the diagnostic power of gynecological fluid.

In MiMARK we have standardized the handling of gynecological fluid samples to ensure reproducibility, stability and seamless implementation in clinical laboratories. We have developed a curated pipeline that translates protein biomarker candidates from high-throughput Mass Spectrometry Data into Proprietary Key Reagents development and validated Immunoassays.

GyLDa

Gynecological Liquid Diagnostics platform

Proof of Concept Prototype Development Clinical Validation GyLDEC Endometrial Cancer Diagnosis GyLDEndo Endometriosis Diagnosis +2000 uterine fluids and clinical data. Proprietary AB and Immunoassay locked-down + 200 cervical fluids and clinical data MS Discovery in 200 patients

Gynecological Liquid Diagnostics platform



Leveraging gynecological fluids to transform how care is delivered.

Gyldec Background
Gyldec Logo

Endometrial cancer diagnosis
Gyldendo Background
Gyldendo Logo

Endometriosis diagnosis